Literature DB >> 9449027

Carbohydrate and peptide structure of the alpha- and beta-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma.

M M Elliott1, A Kardana, J W Lustbader, L A Cole.   

Abstract

Human chorionic gonadotropin (hCG), purified from the urine of 14 individuals with normal pregnancy, diabetic pregnancy, hydatidiform mole, or choriocarcinoma, plus two hCG standard preparations, was examined for concurrent peptide-sequence and asparagine (N)- and serine (O)-linked carbohydrate heterogeneity. Protein-sequence analysis was used to measure amino-terminal heterogeneity and the "nicking" of internal peptide bonds. The use of high-pH anion-exchange chromatography coupled with the increased sensitivity of pulsed amperometric detection (HPAE/PAD) revealed that distinct proportions of both hCG alpha- and beta-subunits from normal and aberrant pregnancy are hyperglycosylated, and that it is the extent of the specific subunit hyperglycosylation that significantly increases in malignant disease. Peptide-bond nicking was restricted to a single linkage (beta 47-48) in normal and diabetic pregnancy, but occurred at two sites in standard preparations, at three sites in hydatidiform mole, and at three sites in choriocarcinoma beta-subunit. In the carbohydrate moiety, alpha-subunit from normal pregnancy hCG contained nonfucosylated, mono- and biantennary N-linked structures (49.3 and 36.7%, means); fucosylated biantennary and triantennary oligosaccharides were also identified (7.3 and 6.9%). In choriocarcinoma alpha-subunit, the level of fucosylated biantennary increased, offset by a parallel decrease in the predominant biantennary structure of normal pregnancy (P < 0.0001). The beta-subunit from normal pregnancy hCG contained fucosylated and nonfucosylated biantennary N-linked structures; however, mono- and triantennary oligosaccharides were also identified (4.6 and 13.7%). For O-linked glycans, in beta-subunit from normal pregnancy, disaccharide-core structure predominated, whereas tetrasaccharide-core structure was also detected (15.6%). A trend was demonstrated in beta-subunit: the proportions of the nonpredominating N- and O-linked oligosaccharides increased stepwise from normal pregnancy to hydatidiform mole to choriocarcinoma. The increases were: for monoantennary oligosaccharide, 4.6 to 6.8 to 11.2%; for triantennary, 13.7 to 26.7 to 51.5% and, for O-linked tetrasaccharide-core structure, 15.6 to 23.0 to 74.8%. For hCG from individual diabetic pregnancy, the principal N-linked structure (34.7%) was consistent with a biantennary oligosaccharide previously reported only in carcinoma; and sialylation of both N- and O-linked antennae was significantly decreased compared to that of normal pregnancy. Taken collectively, the distinctive patterns of subunit-specific, predominant oligosaccharides appear to reflect the steric effect of local protein structure during glycosylation processes. The evidence of alternative or "hyperbranched" glycoforms on both alpha- and beta-subunits, seen at low levels in normal pregnancy and at increased or even predominant levels in malignant disease, suggests alternative substrate accessibility for Golgi processing enzymes, alpha 1,6 fucosyltransferase and N-acetylglucosaminyltransferase IV, in distinct proportions of subunit molecules.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9449027     DOI: 10.1007/BF02778058

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  39 in total

1.  Differences in the carbohydrate moieties of the common alpha-subunits of human chorionic gonadotropin, luteinizing hormone, follicle-stimulating hormone, and thyrotropin: preliminary structural inferences from direct methylation analysis.

Authors:  B Nilsson; S W Rosen; B D Weintraub; D A Zopf
Journal:  Endocrinology       Date:  1986-12       Impact factor: 4.736

2.  Human chorionic gonadotropin. Amino acid sequence of the hormone-specific COOH-terminal region.

Authors:  H T Keutmann; R M Williams
Journal:  J Biol Chem       Date:  1977-08-10       Impact factor: 5.157

3.  Comparative study of the sugar chains of gamma-glutamyltranspeptidases purified from human hepatocellular carcinoma and from human liver.

Authors:  K Yamashita; K Totani; Y Iwaki; I Takamisawa; N Tateishi; T Higashi; Y Sakamoto; A Kobata
Journal:  J Biochem       Date:  1989-05       Impact factor: 3.387

Review 4.  The glycoprotein hormones: recent studies of structure-function relationships.

Authors:  R J Ryan; M C Charlesworth; D J McCormick; R P Milius; H T Keutmann
Journal:  FASEB J       Date:  1988-08       Impact factor: 5.191

5.  The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG.

Authors:  L A Cole; A Kardana; P Andrade-Gordon; M A Gawinowicz; J C Morris; E R Bergert; J O'Connor; S Birken
Journal:  Endocrinology       Date:  1991-09       Impact factor: 4.736

6.  Site specificity of the chorionic gonadotropin N-linked oligosaccharides in signal transduction.

Authors:  M M Matzuk; J L Keene; I Boime
Journal:  J Biol Chem       Date:  1989-02-15       Impact factor: 5.157

7.  Effects of preventing O-glycosylation on the secretion of human chorionic gonadotropin in Chinese hamster ovary cells.

Authors:  M M Matzuk; M Krieger; C L Corless; I Boime
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

8.  Structures of the asparagine-linked sugar chains of human chorionic gonadotropin.

Authors:  Y Endo; K Yamashita; Y Tachibana; S Tojo; A Kobata
Journal:  J Biochem       Date:  1979-03       Impact factor: 3.387

9.  Site-specific N-glycosylation of human chorionic gonadotrophin--structural analysis of glycopeptides by one- and two-dimensional 1H NMR spectroscopy.

Authors:  G Weisshaar; J Hiyama; A G Renwick
Journal:  Glycobiology       Date:  1991-09       Impact factor: 4.313

10.  Comparison of carbohydrate structure between human chorionic gonadotropin present in urine of patients with trophoblastic diseases and healthy individuals.

Authors:  T Mizuochi; R Nishimura; T Taniguchi; T Utsunomiya; M Mochizuki; C Derappe; A Kobata
Journal:  Jpn J Cancer Res       Date:  1985-08
View more
  23 in total

1.  Lectin chromatography/mass spectrometry discovery workflow identifies putative biomarkers of aggressive breast cancers.

Authors:  Penelope M Drake; Birgit Schilling; Richard K Niles; Akraporn Prakobphol; Bensheng Li; Kwanyoung Jung; Wonryeon Cho; Miles Braten; Halina D Inerowicz; Katherine Williams; Matthew Albertolle; Jason M Held; Demetris Iacovides; Dylan J Sorensen; Obi L Griffith; Eric Johansen; Anna M Zawadzka; Michael P Cusack; Simon Allen; Matthew Gormley; Steven C Hall; H Ewa Witkowska; Joe W Gray; Fred Regnier; Bradford W Gibson; Susan J Fisher
Journal:  J Proteome Res       Date:  2012-03-13       Impact factor: 4.466

2.  Development and characterization of antibodies to a nicked and hyperglycosylated form of hCG from a choriocarcinoma patient: generation of antibodies that differentiate between pregnancy hCG and choriocarcinoma hCG.

Authors:  S Birken; A Krichevsky; J O'Connor; J Schlatterer; L Cole; A Kardana; R Canfield
Journal:  Endocrine       Date:  1999-04       Impact factor: 3.633

3.  HCG variants, the growth factors which drive human malignancies.

Authors:  Laurence A Cole
Journal:  Am J Cancer Res       Date:  2011-11-20       Impact factor: 6.166

Review 4.  Review: hCG, preeclampsia and regulatory T cells.

Authors:  W Norris; T Nevers; S Sharma; S Kalkunte
Journal:  Placenta       Date:  2011-02-04       Impact factor: 3.481

Review 5.  Extragonadal actions of chorionic gonadotropin.

Authors:  Prajna Banerjee; Asgerally T Fazleabas
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

6.  Antibody recognition of a human chorionic gonadotropin epitope (hCGbeta66-80) depends on local structure retained in the free peptide.

Authors:  Craig R Gregor; Eleonora Cerasoli; James Schouten; Jascindra Ravi; Jerry Slootstra; Adrian Horgan; Glenn J Martyna; Maxim G Ryadnov; Paul Davis; Jason Crain
Journal:  J Biol Chem       Date:  2011-05-18       Impact factor: 5.157

Review 7.  New discoveries on the biology and detection of human chorionic gonadotropin.

Authors:  Laurence A Cole
Journal:  Reprod Biol Endocrinol       Date:  2009-01-26       Impact factor: 5.211

8.  Abnormal biantennary sugar chains are expressed in human chorionic gonadotropin produced in the choriocarcinoma cell line, JEG-3.

Authors:  Shinji Takamatsu; Toshiyuki Katsumata; Noboru Inoue; Toshinori Watanabe; Yasuhisa Fujibayashi; Makoto Takeuchi
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

Review 9.  Gonadotropins in doping: pharmacological basis and detection of illicit use.

Authors:  U-H Stenman; K Hotakainen; H Alfthan
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

10.  Recognition of N-glycoforms in human chorionic gonadotropin by monoclonal antibodies and their interaction motifs.

Authors:  Daoyuan Li; Ping Zhang; Fei Li; Lequan Chi; Deyu Zhu; Qunye Zhang; Lianli Chi
Journal:  J Biol Chem       Date:  2015-08-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.